Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-31

FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Rabeprazole sodium submitted by Ascend Laboratories, LLC. This action approves the referenced generic product under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabeprazole sodium (rabeprazole)

Snippet

SUPPL AP for RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM)